Induction of apoptosis in human MDA-MB-231 cells assessed as early apoptotic cells at 80 ug/ml after 24 hrs by Annexin-V-FITC/propidium iodide staining based FACS analysis relative to control
Induction of apoptosis in human MDA-MB-231 cells assessed as increase in late apoptotic cells at 20 to 40 ug/ml after 24 hrs by Annexin-V-FITC/propidium iodide staining based FACS analysis
Induction of apoptosis in human MDA-MB-231 cells assessed as increase in apoptotic cells after 24 hrs in presence of lapatinib by Annexin-V-FITC/propidium iodide staining based FACS analysis
Induction of apoptosis in human MDA-MB-231 cells assessed as increase in apoptotic cells after 24 hrs in presence of EGFR siRNA by Annexin-V-FITC/propidium iodide staining based FACS analysis
Antitumor activity against human MDA-MB-231 cells xenografted in athymic BALB/c nude mouse assessed as decrease in tumor volume at 1.25 to 5 mg/kg, po administered every two days for 28 days measured post-last dose by caliper method
Down regulation of RAS expression in athymic BALB/c nude mouse xenografted with human MDA-MB-231 cells at 1.25 to 5 mg/kg, sc administered every two days for 28 days by Western blot analysis
Down regulation of PI3K expression athymic BALB/c nude mouse xenografted with human MDA-MB-231 cells at 1.25 to 5 mg/kg, sc administered every two days for 28 days by Western blot analysis
Down regulation of mTOR expression in athymic BALB/c nude mouse xenografted with human MDA-MB-231 cells at 1.25 to 5 mg/kg, sc administered every two days for 28 days by Western blot analysis
Effect on RAF expression in athymic BALB/c nude mouse xenografted with human MDA-MB-231 cells at 1.25 to 5 mg/kg, sc administered every two days for 28 days by Western blot analysis
Induction of ERK phosphorylation in athymic BALB/c nude mouse xenografted with human MDA-MB-231 cells at 1.25 to 5 mg/kg, sc administered every two days for 28 days by Western blot analysis
Down regulation of AKT phosphorylation in athymic BALB/c nude mouse xenografted with human MDA-MB-231 cells at 1.25 to 5 mg/kg, sc administered every two days for 28 days by Western blot analysis
Effect on MEK expression in athymic BALB/c nude mouse xenografted with human MDA-MB-231 cells at 1.25 to 5 mg/kg, sc administered every two days for 28 days by western blot analysis
Effect on MEK phosphorylation in athymic BALB/c nude mouse xenografted with human MDA-MB-231 cells at 1.25 to 5 mg/kg, sc administered every two days for 28 days by western blot analysis
Increase in ERK expression in in athymic BALB/c nude mouse xenografted with human MDA-MB-231 cells at 1.25 to 5 mg/kg, sc administered every two days for 28 days by Western blot analysis